Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
World Health Organization
Fierce Biotech
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO
Officials are planning to study Mapp Biopharmaceutical’s MBP134 and Gilead Sciences’ remdesivir, which saw widespread use against COVID-19.
Eric Sagonowsky
Jun 24, 2026 3:03pm
Gilead, WHO expand antiparasitic collab
May 21, 2026 11:18am
FDA signs off on expansion for GSK's Blujepa to treat gonorrhea
Dec 12, 2025 10:30am
Novo Nordisk Foundation, China answer call for WHO donations
May 21, 2025 2:30pm
Fierce Healthcare
Trump pulls US, the largest donor, out of WHO
Jan 21, 2025 3:45pm
Argentina biotech to produce Pfizer's Prevnar 20 in access push
Jan 16, 2025 8:38am
